Clemex finalizes the strategic alliance with RAL Diagnostics

The alliance based on a Share Swap between the two Corporations licenses
European market distribution of the new Clemex system for Haematology applications

Symbol:  CXG.A-TSX-V
www.clemex.com
Shares Outstanding23,999,810

MONTREAL, Sept. 8, 2011 /CNW Telbec/ - Clemex Technologies Inc. (TSXV: CXG.A) announces it has received the TSX Exchange approval and has finalized the strategic alliance with its European partner RAL Diagnostics located in Martillac, France, to whom no previous business links existed. This alliance will notably support the marketing of its new instrument being developed for the Haematology sector. According to the partnership signed between the two Corporations, RAL will immediately become the exclusive distributor of the new microscopy instruments developed by Clemex for haematology and other life sciences applications in Europe.

Clemex, on the other hand, developed its new instrument for haematology to primarily use the new MCDH stain solution created by RAL and will also engage in working to develop new microscopy instruments in the future using the various staining solutions created and manufactured by RAL.

A commercial partnership in Europe

RAL Diagnostic immediately becomes dealer of other image analysis products manufactured by Clemex for all other microscopy applications in France, Belgium and Switzerland. Finally, RAL will become the privileged business partner of Clemex products for all of Europe within a year, and will eventually become in charge of all commercial activities such as distribution and marketing for all of Europe. With such an important partner, Clemex, which was only partially present in Europe, will strengthen its presence and should increase its sales significantly to reach North America sales levels in the near future.

Business transaction

With completion of this transaction, Clemex holds 10% of RAL Diagnostics share capital. RAL obtains in return 3 250 000 voting shares issued by Clemex, representing 13.5% of all outstanding voting shares issued by the Company. RAL Diagnostics, which already held 750 000 shares from a private placement concluded in 2008, will then hold, 16.7% of the outstanding voting shares of Clemex.

Financial Information

RAL, which has a complementary microscopy line of products to those of the image analysis microscopy products sold by Clemex, has a Sales Volume, Net Equity and a Company size of about 30% higher than Clemex.

(In Canadian dollars)

  Total Assets
March 31, 2011
RAL (April 30   2011, Clemex)
Total Debts
March 31
RAL (April
30 2011, Clemex)
Net Equity,
March 31
2011, RAL
(30 avril, 2011, Clemex)
Sales volume of
the last 4 fiscal
years (12 months periods) 
Sales in 2011
(12 months)
Net Income in 2011,
(12 months)
Nbr.
Of Employees
  $ $ $ $ $ $  
RAL1   4,7 M 2   2,5 M 3   2.2 M 4 25.8 M 6.6 M 510 276 40
Clemex 2,9 M 1,6 M 1,3 M 19.7 M 5.3 M 323 070 28

Note 1; French accounting reports (unaudited), French standards, Accounting rules committee (ARC)
Note 2; 3,5 M Euros converted in Canadians dollars at a rate of 1.36
Note 3; 1.9 M Euros converted in Canadians dollars at a rate of 1.36
Note 4; 1,6 M Euros converted in Canadians dollars at a rate of 1.36 

About RAL Diagnostics

RAL Diagnostics is a manufacturer of biological stains intended for the field of human and animal health, scientific research, medical diagnosis, and industry. These stains are available in liquids or ready to use kits. RAL Diagnostics serves 6,000 medical analysis laboratories and anatomopathology laboratories of France thanks to a network of 35 distributors and 180 representatives. The company is present in more than 40 countries in the world.

About Clemex Technologies Inc.

Clemex Technologies Inc. develops, manufactures and markets image analysis systems and software used by quality control and research microscopy laboratories.  Clemex customer base spans over many countries in America, Europe, Asia and encompasses major Research and Development Centers, prestigious Universities and large manufacturing industries in various fields including healthcare, automotive, aerospace, raw materials manufacturing, pharmaceuticals, mining and other sectors.

 

SOURCE CLEMEX TECHNOLOGIES INC.

For further information:

Clemex Technologies Inc,
800 Guimond,
Longueuil, QC, Canada J4G 1T5,

Contact:

Clément Forget
Tel: 450.651.6573
Email: ir@clemex.com

Profil de l'entreprise

CLEMEX TECHNOLOGIES INC.

Renseignements sur cet organisme


FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.